Plague

BIODEFENSE: Research Methodology and Animal Models

Volumn , Issue , 2005, Pages 107-135

  Adamovicz, Jeffery J ^a   Worsham, Patricia L ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744550720     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038118-12     Document Type: Chapter

References (131)

1. Poland, J.D. and Dennis, D.T., Plague, in Infectious Diseases of Humans: Epidemiology and Control, Evans, A.S. and Brachman, P.S., Eds., Plenum: New York, 1998, 545-558.
2. Hinnebusch, B.J., Bubonic plague: a molecular genetic case history of the emergence of an infectious disease, J. Mol. Med., 75, 645, 1997.
3. Tigertt, W.D., Plague, in Bacterial Infections of Humans, Evans, A.S. and Brachman, P.S., Eds., Plenum: New York, 1991, 513-523.
4. Doll, J.M., et al., Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona, Am. J. Trop. Med. Hyg., 51, 109, 1994.
5. Gage, K.L., et al., Cases of cat-associated human plague in the Western US, 1977-1998, Clin. Infect. Dis., 30, 893, 2000.
6. Perry, R.D. and Fetherston J.D., Yersinia pestis - etiologic agent of plague, Clin. Microbiol. Rev., 10, 35, 1997.
7. McEvedy, C., The bubonic plague, Sci. Am., 258, 118, 1988.
8. Dennis, D.T., Plague as an emerging disease, in Emerging Infections 2, Scheld, W.M., Craig, W.A. and Hughes, J.M., Eds., ASM Press: Washington, DC, 1998.
9. Bercovier, H. and Mollaret, H.M., Yersinia, in Bergey’s Manual of Systematic Bacteriology, Kreig, N.R. and Holt, J.G., Eds., Williams and Wilkens: Baltimore, MD, 1984, 498-503.
10. Bercovier, H., et al., Intra-and interspecies relatedness of Yersinia pestis by DNA hybridization and its relationship to Yersinia pseudotuberculosis, Curr. Microbiol., 4, 225, 1980.
11. Achtman, M., et al., Microevolution and history of the plague bacillus, Yersinia pestis. Proc. Natl. Acad. Sci. USA, 101, 17837, 2004.
12. Bockemuhl, J. and Wong, J.D., Yersinia, in Manual of Clinical Microbiology, Murray, P.R., Ed., ASM Press: Washington, DC, 2003, 672-683.
13. Achtman, M., et al., Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis, Proc. Natl. Acad. Sci. USA, 96, 14043, 1999.
14. Guiyoule, A., et al., Plague pandemics investigated by ribotyping of Yersinia pestis strains, J. Clin. Microbiol., 32, 634, 1994.
15. Worsham, P.L. in Annual Meeting of the American Society for Microbiology. New Orleans, LA, 2004.
16. Worsham, P.L. and Roy, C., Pestoides F, a Yersinia pestis strain lacking plasminogen activator, is virulent by the aerosol route, Adv. Exp. Med. Biol., 529, 129, 2003.
17. CDC, ASM, and APHL, Basic protocols for level A laboratories for the presumptive identification of Yersinia pestis, Morse, S.A., Ed., Centers for Disease Control, Atlanta, GA, 2002.
18. Dennis, D.T., et al., WHO/CDS/CSR/EDC/99.2 Plague Manual: Epidemiology, Distribution, Surveillance, and Control. Communicable Disease Surveillance and Response Publications, World Health Organization: Geneva, Switzerland, 1999.
19. Thullier, P., et al., Short report: serodiagnosis of plague in humans and rats using a rapid test, Am. J. Trop. Med. Hyg., 69, 450, 2003.
20. Radnedge, L., et al., Identification of nucleotide sequences for the specific and rapid detection of Yersinia pestis, Appl. Environ. Microbiol., 67, 3759, 2001.
21. Zhou, D., et al., Identification of signature genes for rapid and specific characterization of Yersinia pestis, Microbiol. Immunol., 48, 263, 2004.
22. Higgins, J.A., et al., 5' nuclease PCR assay to detect Yersinia pestis, J. Clin. Microbiol., 36, 2284, 1998.
23. Engelthaler, D.M., et al., PCR detection of Yersinia pestis in fleas: comparison with mouse inoculation, J. Clin. Microbiol., 37, 1980, 1999.
24. McGovern, T.W. and Friedlander, A.M., Plague, in Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Zajtchuk, R., Ed., Office of the Surgeon General: Washington, D.C., 1997, 479-502.
25. Butler, T., Plague, in Plague and other Yersinia Infections, Greenough, W.B., and Harigan, T.C., Eds., Plenum: New York, 1983, 73-108.
26. Poland, J.D. and Barnes, A.M., Plague, in CRC handbook series in zoonoses. Section A. Bacterial, rickettsial, chlamydial, and mycotic diseases, Steele, J.H., Ed., CRC Press: Boca Raton, Fla., 1979, 515-559.
27. Pollitzer, R., Plague. WHO Monogr. Ser., 22, 1, 1954.
28. Dennis, D.T. and Meier, F.A., Plague, in Pathology of Emerging Infections, Horsburgh, C.R. and Nelson, A.M., Eds., ASM Press: Washington, DC, 1997.
29. Smith, J.H. and Reisner, B.S., Plague, in Pathology of Infectious Diseases, Conner, D.H., Ed., Prentice Hall: NJ, 1997, 729-738.
30. Rollins, S.E., Rollins, D.M. and Ryan, E.T., Yersinia pestis and the plague, Am. J. Clin. Pathol., 119 Suppl, S78, 2003.
31. Inglesby, T.V., et al., Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense, JAMA, 283, 2281, 2000.
32. Finegold, M.J., et al., Studies on the pathogenesis of plague. Blood coagulation and tissue responses of Macaca mulatta following exposure to aerosols of Pasteurella pestis, Am. J. Pathol., 53, 99, 1968.
33. Crook, L.D. and Tempest, B., Plague. A clinical review of 27 cases, Arch. Intern. Med., 152, 1253, 1992.
34. Benner, G.E., et al., Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice, Infect. Immun., 67, 1922, 1999.
35. Rust, J.H., Jr., et al., Susceptibility of rodents to oral plague infection: a mechanism for the persistence of plague in inter-epidemic periods, J. Wildl. Dis., 8, 127, 1972.
36. Tieh, T.H., Primary pneumonic plague in Mukden, 1946, and report of 39 cases with 3 recoveries, J. Infect. Dis., 82, 52, 1948.
37. Christie, A.B., Chen, T.H. and Elberg, S.S., Plague in camels and goats: their role in human epidemics, J. Infect. Dis., 141, 724, 1980.
38. Meyer, K.F., Pasturella and Francisella, in Bacterial and Mycotic Infections in Man, Dubos, R.J. and Hirsch, J.G., Eds., Lippincott: Philadelphia, 1965, 659-697.
39. Cleri, D.J., et al., Plague pneumonia disease caused by Yersinia pestis, Semin. Respir. Infect., 12, 12, 1997.
40. Williams, J.E., et al., Potency of killed plague vaccines prepared from avirulent Yersinia pestis, Bull. World Health Organ., 58, 753, 1980.
41. von Metz, E., Eisler, D.M. and Hottle, G.A., Immunogenicity of plague vaccines in mice and guinea pigs, Appl. Microbiol., 22, 84, 1971.
42. Anderson, G.W., Jr., et al., Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis, Am. J. Trop. Med. Hyg., 56, 471, 1997.
43. Elvin, S.J. and Williamson, E.D., Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague, Microb. Pathog., 37, 177, 2004.
44. Elvin, S.J., et al., Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infection, Nature, 430, 1 (1 p following 417), 2004.
45. Green, M., et al., The SCID/Beige mouse as a model to investigate protection against Yersinia pestis, FEMS Immunol. Med. Microbio.l, 107, 1999.
46. Anderson, G.W., Jr., et al., Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis, Infect. Immun., 64, 4580, 1996.
47. Simpson, W.J., Thomas, R.E. and Schwan, T.G., Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice, Am. J. Trop. Med. Hyg., 43, 389, 1990.
48. Eyles, J.E., et al., Intra nasal administration of poly-lactic acid microsphere coencapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse, Vaccine, 16, 698, 1998.
49. Garmory, H.S., et al., Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen, Vaccine, 22, 947, 2004.
50. Russell, P., et al., Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection, J. Antimicrob. Chemother., 41, 301, 1998.
51. Byrne, W.R., et al., Antibiotic treatment of experimental pneumonic plague in mice, Antimicrob. Agents Chemother., 42, 675, 1998.
52. Rahalison, L., et al., Failure of oily chloramphenicol depot injection to treat plague in a murine model, J. Antimicrob. Chemother., 45, 541, 2000.
53. Steward, J., et al., Efficacy of the latest fluoroquinolones against experimental Yersinia pestis, Int. J. Antimicrob. Agents, 24, 609, 2004.
54. Jones, S.M., et al., Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains, Vaccine, 19, 358, 2001.
55. Brandler, P., et al., Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive, J. Immunol., 161, 4195, 1998.
56. Nazarova, L.S., et al., [Morphological study of the damaging effect of an EB vaccine strain of the plague microbe in inbred mice]. Biull. Eksp. Biol. Med., 105, 761, 1988.
57. Russell, P., et al., A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model, Vaccine, 13, 1551, 1995.
58. Welkos, S.L., et al., Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis, Contrib. Microbiol. Immunol., 13, 299, 1995.
59. Davis, K.J., et al., Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops), Arch. Pathol. Lab. Med., 120, 156, 1996.
60. Worsham, P.L., Stein, M.P. and Welkos, S.L., Construction of defined F1 negative mutants of virulent Yersinia pestis, Contrib. Microbiol. Immunol., 13, 325, 1995.
61. Meyer, K.F., Immunity in plague: a critical consideration of some recent studies, J. Immunol., 64, 139, 1950.
62. Walker, D.L., et al., Studies on immunization against plague. V. Multiplication and persistence of virulent and avirulent Pasteurella pestis in mice and guinea pigs, J. Immunol., 70, 245, 1953.
63. Titball, R.W. and Williamson, E.D., Vaccination against bubonic and pneumonic plague, Vaccine, 19, 4175, 2001.
64. Meyer, K.F., Pneumonic plague, Bacteriol. Rev., 25, 249, 1961.
65. Martini, E., Ueber inhalationspest der ratten, Z. Hyg. Infektionskrankh, 38, 332, 1901.
66. Meyer, K.F. and Larson, A. The pathogenesis of cervical septicemic plague developing after exposure to pneumonic plague produced by intratracheal infection in primates, in Proc. Symp. Diamond Jubilee Haffkine Inst., Jan. 10-14, 1959, 1-12. Bombay, India, 1960.
67. Wang, S., et al., A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague, Vaccine, 22, 3348, 2004.
68. Meyer, K.F., Quan, S.F. and Larson, A. Prophylactic immunization and specific therapy of experimental pneumonic plague, in 43rd Annual Meeting of the National Tuberculosis Association, San Francisco, California, June 19, 1947.
69. Meyer, K.F., Quan, S.F. and Larson, A., Prophylactic immunization and specific therapy of experimental pneumonic plague, Am. Rev. Tuberc., 57, 312, 1948.
70. Straley, S.C. and Bowmer, W.S., Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins, Infect. Immun., 51, 445, 1986.
71. Butler, T., et al., Experimental Yersinia pestis infection in rodents after intragastric inoculation and ingestion of bacteria, Infect. Immun., 36, 1160, 1982.
72. Kokushkin, A.M., et al., [The results of the measured oral infection of white mice with strains of the causative agent of plague differing in their plasmid profile], Zh. Mikrobiol. Epidemiol. Immunobiol., 2, 15, 1994.
73. Spivak, M.L., et al., The immune response of the guinea pig to the antigens of Pasteurella pestis, J. Immunol., 80, 132, 1958.
74. Lawton, W.D., Fukui, W.D. and Surgalla, M.J., Studies on the antigens of Pasteurella pestis and Pasteurella pseudotuberculosis, J. Immunol., 84, 475, 1960.
75. Chen, T.H., Foster, L.E. and Meyer, K.F., Comparison of the immune response to three different Yersinia pestis vaccines in guinea pigs and langurs, J. Infect. Dis., 129 (Suppl), S53, 1974.
76. Meyer, K.F., et al., Experimental appraisal of antiplague vaccination with dead virulent and living avirulent plague bacilli, Proc. Fourth Int. Cong. Trop. Med., 1948, 264. Proc. Fourth Int. Cong. Trop. Med. and Malaria, Washington, DC, May 10-18, 1948, 264.
77. Jones, S.M., et al., Protective efficacy of a fully recombinant plague vaccine in the guinea pig, Vaccine, 21, 3912, 2003.
78. Jawetz, E. and Meyer, K.F., The behavior of virulent and avirulent P. pestis in normal and immune experimental animals, J. Infect. Dis., 74, 1, 1944.
79. Meyer, K.F., et al., Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs, J. Infect. Dis., 129(Suppl), S85, 1974.
80. Anisimov, A.P., Lindler, L.E. and Pier, G.B., Intraspecific diversity of Yersinia pestis, Clin. Microbiol. Rev., 17, 434, 2004.
81. Kovaleva, R.V., Certain characteristics of Pasteurella pestis strains isolated from Microtus brandii and other rodents, Zh. Mikrobiol. Epidemiol. Immunobiol., 8, 30, 1958.
82. Lebedinskii, V.A., et al., [Experience using fraction I of the plague microbe for revaccinating experimental animals], Zh. Mikrobiol. Epidemiol. Immunobiol., 5, 60, 1982.
83. Smith, H. and Packman, L.P., A filtered non-toxic plague vaccine which protects guinea-pigs and mice, Br. J. Exp. Pathol., 47, 25, 1966.
84. Burrows, T.W. and Bacon, G.A., The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Yersinia pestis, Br. J. Exp. Pathol., 39, 278, 1958.
85. Burrows, T.W. and Gillett, W.A., Host specificity of Brazilian strains of Pasteurella pestis, Nature, 229, 51, 1971.
86. Wayson, N.E., McMahon, C. and Prince, F.M., An evaluation of three plague vaccines against infection in guinea pigs induced by natural and artificial methods, Public Health Rep., 61, 1511, 1946.
87. Martini, E., Ueber die wirkung des pestserums bei experimenteller pestpneumonie an ratten, mausen, meerschweinchen, und kaninchen, Klin. Jahrb., 10, 137, 1902.
88. Strong, R.P. and Teague, O., Studies on pneumonic plague and plague immunization. VIII. Susceptibility of animals to pneumonic plague, Phillip J. Sci., 7B, 223, 1912.
89. Strong, R.P. and Teague, O., Studies on pneumonic plague and plague immunization, Phillip J. Sci., 7B, 173, 1912.
90. Druett, H.A., et al., Studies on respiratory infection. II. The influence of aerosol particle size on infection of the guinea pig with Pasteurella pestis, J. Hyg. (Lond), 54, 37, 1956.
91. Bablet, J. and Girard, G., Lesions histologiques dans le peste pulmonaire primitive experimentale du cobaye, Ann. Inst. Pasteur (Paris), 52, 155, 1934.
92. Smit, A.A. and Van der Bank, H.F., Isozyme and allozyme markers distinguishing two morphologically similar, medically important Mastomys species (Rodentia: Muridae), BMC Genet., 2, 15, 2001.
93. Green, C.A., Gordon, D.H. and Lyons, N.F., Biological species in Praomys (Mastomys) natalensis (Smith), a rodent carrier of Lassa virus and bubonic plague in Africa, Am. J. Trop. Med. Hyg., 27, 627, 1978.
94. Shepherd, A.J., et al., Comparative tests for detection of plague antigen and antibody in experimentally infected wild rodents, J. Clin. Microbiol., 24, 1075, 1986.
95. Shepherd, A.J., Leman, P.A. and Hummitzsch, D.E., Experimental plague infection in South African wild rodents, J. Hyg. (Lond), 96, 171, 1986.
96. Arntzen, L., Wadee, A.A. and Isaacson, M., Immune responses of two Mastomys sibling species to Yersinia pestis, Infect. Immun., 59, 1966, 1991.
97. Hallett, A.F., Evaluation of live attenuated plague vaccines in Praomys (Mastomys) natalensis, Infect. Immun., 18, 8, 1977.
98. Williams, J.E. and Cavanaugh, D.C., Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis), Experientia, 40, 739, 1984.
99. Chen, T.H. and Meyer, K.F., Susceptibility and antibody response of Rattus species to experimental plague, J. Infect. Dis., 129(Suppl), S62, 1974.
100. Williams, J.E. and Cavanaugh, D.C., Measuring the efficacy of vaccination in affording protection against plague, Bull. World Health Org., 57, 309, 1979.
101. Otten, L., Immunization against plague with live vaccine, Indian J. Med. Res., 24, 73, 1936.
102. Williams, J.E., et al., Antibody and resistance to infection with Yersinia pestis in the progeny of immunized rats, J. Infect. Dis., 129(Suppl), S72, 1974.
103. Williams, J.E., Moussa, M.A. and Cavanaugh, D.C., Experimental plague in the California ground squirrel, J. Infect. Dis., 140, 618, 1979.
104. Quan, T.J., et al., Experimental plague in rock squirrels, Spermophilus variegatus (Erxleben), J. Wildl. Dis., 21, 205, 1985.
105. McCoy, G.W., Studies on plague in ground squirrels, Public Health Bull., 43, 1911.
106. Hubbert, W.T. and Goldenberg, M.I., Natural resistance to plague: genetic basis in the vole (Microtus californicus), Am. J. Trop. Med. Hyg., 19, 1015, 1970.
107. Swearengen, J.R. and Worsham, P.L., Plague, in Emerging Diseases of Animals, Brown, C. and Bolin, C, Eds., ASM Press: Washington, D.C., 2000, 259-279.
108. Anisimov, A.P., [Factors of Yersinia pestis providing circulation and persistence of plague pathogen in ecosystems of natural foci. Communication 2], Mol. Gen. Mikrobiol. Virusol., 4, 3, 2002.
109. Anisimov, A.P., [Yersinia pestis factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1], Mol. Gen. Mikrobiol. Virusol., 3, 3, 2002.
110. Ehrenkranz, N.J. and Meyer, K.F., Studies on immunization against plague. VIII. Study of three immunizing preparations in protecting primates against pneumonic plague, J. Infect. Dis., 96, 138, 1955.
111. Hinnebusch, B.J., Gage, K.L. and Schwan, T.G., Estimation of vector infectivity rates for plague by means of a standard curve-based competitive polymerase chain reaction method to quantify Yersinia pestis in fleas, Am. J. Trop. Med. Hyg., 58, 562, 1998.
112. SIPRI, The problem of chemical and biological warfare, in Chemical Biological Weapons Today, Stockholm International Peace Research Insititute, Ed., Humanities: New York, 1973, 3.
113. Speck, R.S. and Wolochow, H., Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus, J. Infect. Dis., 100, 58, 1957.
114. Ehrenkranz, N.J. and White, L.P., Hepatic function and other physiologic studies in monkeys with experimental pneumonic plague, J. Infect. Dis., 95, 226, 1954.
115. Ransom, J.P. and Krueger, A.P., Chronic pneumonic plague in Macaca mulatta, Am. J. Trop. Med. Hyg., 3, 1040, 1954.
116. Finegold, M.J., Pathogenesis of plague. A review of plague deaths in the United States during the last decade. Am. J. Med., 45, 549, 1968.
117. Chen, T.H. and Meyer, K.F., Susceptibility and immune response to experimental plague in two species of langurs and in African green (grivet) monkeys. J. Infect. Dis., 129(Suppl), S46, 1974.
118. Hallett, A.F., Isaacson, M. and Meyer, K.F., Pathogenicity and immunogenic efficacy of a live attenuated plaque vaccine in vervet monkeys. Infect. Immun., 8, 876, 1973.
119. Chen, T.H., Elberg, S.S. and Eisler, D.M., Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis, J. Infect. Dis., 135, 289, 1977.
120. Chen, T.H. and Meyer, K.F., Susceptibility of the langur monkey (Semnopithecus entellus) to experimental plague: pathology and immunity, J. Infect. Dis., 115, 456, 1965.
121. Romanov, V.E., et al., [Standardization of conditions for the evaluation of effectiveness of antibacterial drugs in pneumonic plague in sacred baboons]. Antibiot. Khimioter., 40, 23, 1995.
122. Romanov, V.E., et al., [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys]. Antibiot. Khimioter., 46, 16, 2001.
123. Byvalov, A.A., et al., [Effectiveness of revaccinating hamadryas baboons with NISS live dried plague vaccine and fraction I of the plague microbe], Zh. Mikrobiol. Epidemiol. Immunobiol., 4, 74, 1984.
124. Rust, J.H., Jr., et al., The role of domestic animals in the epidemiology of plague. I. Experimental infection of dogs and cats, J. Infect. Dis., 124, 522, 1971.
125. Rust, J.H., Jr., et al., The role of domestic animals in the epidemiology of plague. II. Antibody to Yersinia pestis in sera of dogs and cats, J. Infect. Dis., 124, 527, 1971.
126. Gage, K.L., Montenieri. J.A. and Thomas, R.E.. The role of predators in the ecology, epidemiology, and surveillance of plague in the United States, in Proc. 16th Vertebr. Pes. Conf. University of California, Davis, 200-206, 1994.
127. Carlson, M.E., Yersinia pestis infection in cats, Feline Pract., 24, 22, 1996.
128. Gasper, P.W., et al., Plague (Yersinia pestis) in cats: description of experimentally induced disease, J. Med. Entomol., 30, 20, 1993.
129. Eidson, M., Thilsted, J.P. and Rollag, O.J., Clinical, clinicopathologic, and pathologic features of plague in cats: 119 cases (1977-1988), J. Am. Vet. Med. Assoc., 199, 1191, 1991.
130. Herzog, M., The plague: Bacteriology, morbid anatomy, and histopathology, D.O.T. Interior, Ed., 1904, Manila Bureau of Public Printing, 1904, 3-149.
131. Supplemental Issue, J. Infect. Dis., 129, 1-120, 1974.